Guiying Nie of the Prince Henry's Institute of Medical Research in Australia will develop a new assay to measure a protein that is produced by the placenta during its development, and will test the theory that monitoring this protein can reflect placental abnormalities that indicate a high risk for preeclampsia very early in pregnancy. If successful, identifying high-risk pregnancies very early can lead to targeted intervention, saving lives and reducing health care costs.
Information taken from Gates Foundation Grand Challenges Exploration Grants, awarded grants summaries.
Funding Source
Bill & Melinda Gates Foundation